Humira 40 mg/0.4 ml

Humira 40 mg/0.4 ml is a medicine authorised by Swissmedic under authorisation number 57862. The authorisation holder is AbbVie AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 March 2007 and the authorisation is valid without a time limit. ATC code L04AB04 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 57862
  • ATC L04AB04
  • Biotechnological medicines
Authorisation data
Authorisation number57862
NameHumira 40 mg/0.4 ml
Full nameHumira 40 mg/0.4 ml, Injektionslösung im Fertigpen
Authorisation holderAbbVie AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AB04
First authorisation20 March 2007
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
3Humira 40 mg/0.4 ml, Injektionslösung im FertigpenB23 December 2016
4Humira 80 mg/0.8 ml, Injektionslösung im FertigpenB15 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
31Injektor(en), vorgefüllt/PenL04AB0407.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Humira 40 mg/0.4 ml authorised in Switzerland?

Yes. Humira 40 mg/0.4 ml is authorised by Swissmedic under authorisation number 57862, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Humira 40 mg/0.4 ml have?

Humira 40 mg/0.4 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Humira 40 mg/0.4 ml?

The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com